Literature DB >> 6808106

Communicability of Pseudomonas aeruginosa in a cystic fibrosis summer camp.

D P Speert, D Lawton, S Damm.   

Abstract

Entities:  

Mesh:

Year:  1982        PMID: 6808106     DOI: 10.1016/s0022-3476(82)80127-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  12 in total

1.  Evaluation of random amplified polymorphic DNA typing of Pseudomonas aeruginosa.

Authors:  M Campbell; E Mahenthiralingam; D P Speert
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

Review 2.  Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.

Authors:  J R Govan
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

Review 3.  Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.

Authors:  Andrew M Jones; A Kevin Webb
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

4.  Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis.

Authors:  D P Speert; S W Farmer; M E Campbell; J M Musser; R K Selander; S Kuo
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

5.  Use of a pilin gene probe to study molecular epidemiology of Pseudomonas aeruginosa.

Authors:  D P Speert; M E Campbell; S W Farmer; K Volpel; A M Joffe; W Paranchych
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

Review 6.  Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management.

Authors:  N Høiby; C Koch
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

7.  Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study.

Authors:  R Mahadeva; K Webb; R C Westerbeek; N R Carroll; M E Dodd; D Bilton; D A Lomas
Journal:  BMJ       Date:  1998-06-13

8.  Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients.

Authors:  M J Struelens; V Schwam; A Deplano; D Baran
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

9.  Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients.

Authors:  B Tümmler; U Koopmann; D Grothues; H Weissbrodt; G Steinkamp; H von der Hardt
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

Review 10.  Infection control in cystic fibrosis.

Authors:  Lisa Saiman; Jane Siegel
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.